International Clinical Trial: Effect of Lactobacillus rhamnosus GG ATCC 53103 Supplementation in Infants Born by C Section

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116820) titled 'Effect of Lactobacillus rhamnosus GG ATCC 53103 Supplementation in Infants Born by C Section' on Sept. 1.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Investigator Blinded

Primary Sponsor: Tablets India Ltd

Intervention: Intervention1: Lactobacillus rhamnosus GG ATCC 53103 drops. Brand used is Bifilac GG Drops: 0.25 ml of Lactobacillus rhamnosus GG ATCC 53103 d...